Avoiding, Treating & Curing Cancer With the Immune System | Dr. Alex Marson
•March 9, 2026
0
Why It Matters
By turning the immune system into a programmable therapy, CAR‑T and gene‑editing technologies promise faster, more personalized cancer cures, reshaping biotech investment and clinical practice.
Key Takeaways
- •CAR‑T cell therapy reprograms T cells to target cancer
- •Gene editing tools like CRISPR enable precise immune modulation
- •AI and large‑scale sequencing accelerate discovery of therapeutic targets
- •Thymus educates T cells via positive and negative selection
- •Lifestyle factors (smoking, charred meat) still influence cancer risk
Summary
In this Huberman Lab episode, Dr. Alex Marson explains how cutting‑edge biology is turning the immune system into a programmable weapon against cancer. He walks listeners through the fundamentals of innate and adaptive immunity, the random generation of T‑cell receptors, and the crucial education that occurs in the thymus before T cells are released into circulation.
Marson highlights the convergence of DNA sequencing, CRISPR gene editing, lipid‑nanoparticle delivery and artificial‑intelligence analytics that now lets scientists rewrite specific DNA sequences inside immune cells. By testing every gene’s role, researchers can engineer CAR‑T cells—T cells equipped with lab‑designed chimeric antigen receptors—to hunt and destroy tumors with unprecedented precision. He stresses that this is no longer a theoretical pill but a direct instruction set written in DNA.
A memorable quote from the interview captures the shift: “We can actually talk to our own cells and give them instructions in the language of DNA.” He uses the CAR‑T example to illustrate how a synthetic receptor, absent in nature, can be infused back into a patient’s bloodstream, turning the patient’s own T cells into cancer‑killing agents. The discussion also touches on everyday cancer risks—smoking, UV exposure, charred meats, and even airport scanners—underscoring that immune engineering complements, not replaces, lifestyle prevention.
The implications are profound: personalized immunotherapies could move from niche trials to standard oncology care within a decade, while AI‑driven genomics shortens target discovery cycles. For investors, biotech firms mastering cell programming and delivery platforms are poised for rapid growth, and for clinicians, a new toolkit for tackling both adult and pediatric cancers is emerging.
Original Description
Dr. Alex Marson, MD, PhD, is a professor of medicine at the University of California, San Francisco. We discuss the biology of the immune system and cancer, and everyday choices that can increase or decrease your cancer risk, several of which are surprising but all of which are actionable. We also discuss immunotherapy, including how engineered T-cells can be used to defeat childhood and adult cancers. Dr. Marson explains CRISPR and gene editing to cure diseases, and we address the ethical questions surrounding gene editing in embryos, children and adults. This discussion is for anyone interested in avoiding cancer and/or seeking to understand the science and practical applications of immune- or gene-therapy.
Show notes: https://go.hubermanlab.com/oBv3wjv
Thank you to our sponsors
BetterHelp: https://betterhelp.com/huberman
Helix Sleep: https://helixsleep.com/huberman
Function: https://functionhealth.com/huberman
Huberman Lab
Threads: https://www.threads.net/@hubermanlab
Newsletter: https://www.hubermanlab.com/newsletter
Dr. Alex Marson
Timestamps
00:00:00 Alex Marson
00:02:21 Diseases & Current Biological Landscape; AI & Computational Tools
00:05:56 Immune System, Innate vs Adaptive Immune System
00:10:55 Thymus, T Cell Selection; B Cells & Antibodies
00:13:23 Sponsors: BetterHelp & Helix Sleep
00:16:11 Immune System Health, Sleep, Diet; Genes
00:20:56 Childhood Exposure & Allergy Prevention; Autoimmune Reactions
00:25:27 Whole Body Immune Response, Cytokines & Fever; Antibiotics
00:30:51 Cancer; Mutations & Cell Regulation; Smoking, BRCA Mutations, Sunlight
00:38:27 BRAC Mutations, Mutagens, Pesticides
00:42:33 Sponsor: AG1
00:43:57 X-Rays & Airport Scanners, Carcinogen vs Mutagen, Charred Meat, Food Dye
00:49:34 Immune-Based Cancer Treatment, Checkpoint Inhibitors, CAR T-Cell Therapy
00:59:04 CRISPR, Immunotherapies
01:02:52 Age & Cancer Risk; CAR T-Cells, Targets & Side Effects; Ketogenic Diet
01:08:27 CRISPR Discovery & Mechanism
01:17:06 CRISPR Precision, Risk & Benefit; CRISPR Technology Evolution
01:20:57 Sponsor: LMNT
01:22:17 CRISPR Cell Delivery, Clinical Trials; Treating Early Cancers & Prevention
01:33:47 Liposomes, Engineered Viruses, Lipid Nanoparticles (LNPs), Vaccines
01:39:57 COVID Pandemic & Trust in Science, mRNA Vaccine
01:47:51 Sponsor: Function
01:49:39 Drug Delivery to Cancer, Immunotoxins, T-Cell Engagers; AI Protein Targets
01:55:45 CRISPR Embryo Modification, Ethics; Heritable Gene Editing, Diversity
02:05:42 Deep Sequencing Embryos, Diversity; Overcoming Adversity & Resilience
02:10:44 Upcoming Therapeutics, Autoimmunity & CAR T-Cells, CRISPR & Gene Function
02:17:55 Banking T Cells or iPSCs?, Future of Cell Programming
02:24:41 Zero-Cost Support, YouTube, Spotify & Apple Follow, Reviews & Feedback, Sponsors, Protocols Book, Social Media, Neural Network Newsletter
#HubermanLab #Science #Health
Disclaimer & Disclosures: https://www.hubermanlab.com/disclaimer
0
Comments
Want to join the conversation?
Loading comments...